Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Purchase of 831 FTH shares, $19.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Faeth Therapeutics, Inc. (FTH) | Purchase | 831 | $19.4K |
| Jun 26, 2026 | Faeth Therapeutics, Inc. (FTH) | Purchase | 2,891 | $72.9K |
| Jun 24, 2026 | Faeth Therapeutics, Inc. (FTH) | Purchase | 1,797 | $36.4K |
| Feb 27, 2025 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 8,500 | $144.5K |
| Feb 20, 2025 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 25,798 | n/a |
| Jan 30, 2025 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 68,000 | $1.16M |
| Dec 13, 2024 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 42,683 | n/a |
| Nov 21, 2024 | BridgeBio Pharma, Inc. (BBIO) | Sale | 4,156 | $93.1K |
| Nov 19, 2024 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 25,799 | n/a |
| Aug 20, 2024 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 25,797 | n/a |